Clinical TrialsSearch results
Number of results: 2568
Recruiting
- A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination with Anti-cancer Agents in Partisipants with Advanced Solid Tumours Expressing Claudin18.2. NOTE: Official Title should have no more than 240 characters.
- Gastric cancer, Gastroesophageal junction cancer, Pancreatic Adenocarcinoma
- Hibi Kazushige
- 2024-01-16
Recruiting
- A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)
- Hepatocellular Carcinoma, Biliary Tract Cancer
- Hibi Kazushige
- 2023-07-27
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26
Completed
- A Phase II/III Study of MR19A13A.
- Patients undergoing a scheduled surgery under general anesthesia.with mask induction.
- Nobuyo Oya
- 2022-10-27
Other
- A phase II/III Study of M610101 in Patients with Atopic Dermatitis
- Atopic dermatitis
- Tomoyuki Nishiura
- 2023-01-12
Completed
- A phase II/III, randomized, active-comparator, observer-blind, non-inferiority study to demonstrate the immunogenicity and safety of DS-5670a/b in children 5 through 11 years of age.
- Prevention of infectious disease by Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
- Inoguchi Akihiro
- 2022-10-20
Recruiting
- A Phase IIb, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants With Dyslipidemia
- Dyslipidemia
- Ageishi Yuji
- 2024-01-22
Other
- A Phase III b study to evaluate P1101 in Japanese PV patients
- Polycythemia Vera
- Kawase Hiroaki
- 2023-07-29
Other
- A Phase III clinical study of LF111 in Japanese women desiring contraception
- Contraception
- Kikuyama Ryoko
- 2022-01-18
Recruiting
- A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Metastatic Castration Resistant Prostate Cancer
- Hibi Kazushige
- 2022-07-14